TMP001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TMP001, covering 2018-11-21 to 2018-11-21. Get the full timeline:
Most recent: Clinical Trial Update: TMP001 in Relapsing-remitting Multiple Sclerosis [Phase 2]